Epilepsy Impact Scale

Completed

• Conditions: Epilepsy
• Interventions: Other: Interviews and questionnaires

• Registration Number: NCT01833234
• Lead Sponsor: Stanford University

Brief Summary

The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.

Detailed Description

The investigators have used a set of broad open-ended questions about the impact of epilepsy on a person's life to formulate a long list of questions to characterize the impact the seizures, medications, and comorbidities that you are having. In the future, this will be boiled down to a short list of questions.

Study Timeline

• Study Start: 2012-07
• Study First Submitted: 2013-03-29
• Study First Submitted QC: 2013-04-12
• Study First Posted: 2013-04-16
• Primary Completion: 2014-09
• Study Completion: 2014-09
• Status Verified: 2016-04
• Last Update Submitted: 2016-04-12
• Last Update Posted: 2016-04-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

1. Age 18 or more.
2. Patient has had at least 1 seizure in the past 365 days.
3. Patient can speak and understand English.

Read More

Exclusion Criteria

1. Patients suspected of having one of the imitators of epilepsy, for example, syncope, sleep disorder, psychogenic nonepileptic seizures, will be excluded, even if they also have epileptic seizures.
2. Patients unwilling to spend the time doing the questionnaire.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
People with epilepsy	Interviews and questionnaires	People with epilepsy who have have had at least one seizure in the prior year.

Primary Outcome Measures

Name	Time	Method
Validation of a concise question set	Up to 1 year for question set validation, data presentation within up to 1.5 years

Secondary Outcome Measures

Name	Time	Method
Correlation of subscales	Up to 1.5 years	Correlation of subscales of the study questionnaire with previously validated scales, including QoLiE-39, NHS Seizure Severity Scale, Liverpool side effects scale, Beck Depression Index

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States